HRJ

official impact factor 1.46

Open Access

Methodology for evaluating Insite: Canada's first medically supervised safer injection facility for injection drug users

Evan Wood*, Thomas Kerr, Elisa Lloyd-Smith, Chris Buchner, David C Marsh, Julio SG Montaner and Mark W Tyndall

Harm Reduction Journal 2004, 1:9 doi:10.1186/1477-7517-1-9

Accesses  

  • Last 30 days: 294 accesses
  • Last year: 3471 accesses
  • All time: 14136 accesses

Cited by

BioMed Central: 4 citations

Research article   Open Access

Unstable housing and hepatitis C incidence among injection drug users in a Canadian setting

Christina Kim, Thomas Kerr, Kathy Li, Ruth Zhang, Mark W Tyndall, Julio SG Montaner, Evan Wood BMC Public Health 2009, 9:270 (29 July 2009)

Research article   Open Access

Risk factors for developing a cutaneous injection-related infection among injection drug users: a cohort study

Elisa Lloyd-Smith, Evan Wood, Ruth Zhang, Mark W Tyndall, Julio SG Montaner, Thomas Kerr BMC Public Health 2008, 8:405 (9 December 2008)

Research   Open Access Highly Accessed

HIV seroprevalence among participants at a Supervised Injection Facility in Vancouver, Canada: implications for prevention, care and treatment

Mark W Tyndall, Evan Wood, Ruth Zhang, Calvin Lai, Julio SG Montaner, Thomas Kerr Harm Reduction Journal 2006, 3:36 (18 December 2006)

Research   Open Access

Potential community and public health impacts of medically supervised safer smoking facilities for crack cocaine users

Kate Shannon, Tomiye Ishida, Robert Morgan, Arthur Bear, Megan Oleson, Thomas Kerr, Mark W Tyndall Harm Reduction Journal 2006, 3:1 (10 January 2006)